The Valley Desk

ArticleClinicoEconomics and outcomes research : CEORPublished

Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
ClinicoEconomics and outcomes research : CEOR
Published
Subject terms
Gene therapy; Retinitis pigmentosa; Blindness; Disability; Inherited Retinal Diseases
PubMed ID
42058269
PubMed Central ID
PMC13123546
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal